New Cannabis Patch to Treat Fibromyalgia and Diabetic Nerve Pain Revealed

Cannabis can be a form of medication, and a company that specialized in this matter has developed a revolutionary pain patch that can be used to treat diabetic nerve pain and symptoms of fibromyalgia. This is a great opportunity for the use of cannabis to be valued for its medicinal properties in the medical world.

The current medications are utilized as transdermal patches, which are simply adhesive patches that are stuck to the skin and release certain chemicals over time which will help to fight against the neurological nerve pain related to diabetes and fibromyalgia. Using this type of administration can be used as well as for cannabis meaning that a controlled dose of the medication can be administered daily, without any negative side effects, detected so far.

Cannabis Science is a company which designed these patches, and regarding their use it conveys the following message:

“Promote healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive which will be containing high potency cannabinoid (CBD) extract that slowly enters into the bloodstream and then penetrates the central nervous system of the patient delivering the pain relief sought.”

Have you heard of CBD and THC?

THC and CBD are the two most important cannabinoids contained in cannabis. CBD is the second major cannabinoid that incorporates amazing pain relieving and anti-inflammatory properties. It is entirely natural with very few side effects, including the hallucinogenic effects commonly related to THC.

This is what Mr. Raymond C Dabney, CEO of Cannabis Science states regarding this matter, quoting:

“The development of these two new pharmaceutical medicinal applications are just the tip of the iceberg for what we see as the future for Cannabis Science. While we strive to increase our land capacity for growth and facilities to produce our own product to supply our scientists with proprietary materials to make these formulations, we are also busy researching more potential needs for Cannabis related medical applications and developing the methods for delivery of these medications.”

Fibromyalgia is a condition that impacts 10% of our population, moreover with a great number of people who have not yet been diagnosed. On the other hand, nerve neuropathy diabetic pain is widely spread around the world and affects many people. This new treatment will be one step forward in limiting certain symptoms, and perhaps even curing these illnesses once for all.

In the end, Mr. Dabney concludes, quoting:

“As more states nationwide legislate for the legalization of cannabis and cannabis-derived medications, we here at Cannabis Science are focused on developing pharmaceutical formulations and applications to supply the huge growing demand expected over the coming few years.”